News - Actavis, Anti-virals, Patents

Filter

Current filters:

ActavisAnti-viralsPatents

News briefs: Rituximab biosimilar; Watson to change name; Baxter Brazil plans; India revokes Pegasys patent

05-11-2012

Swiss drug major Novartis' (NOVN: VX) generics subsidiary Sandoz has initiated a Phase III clinical trial…

ActavisAnti-viralsAsia-PacificBaxter InternationalBiotechnologyGenericsHemobrasMarkets & MarketingNorth AmericaNovartisOncologyPatentsPegasysRegulationrFVIIIrituximabRocheSandozSouth AmericaWatson Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top